The Pharmaceutical Technology Excellence Awards Winners have been announced! To see the full list you can download the full 50+ page report from the following link:
Has your company won an Excellence Award?
Search to find out if your company is a winner
The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change.
Our program is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
Featured Winners
IAG is a leading imaging clinical research organization that combines medical and operational expertise with proprietary cloud-based platform DYNAMIKA for data management and a Category Award Winner for Innovation.
IFF the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products and a Category Award Winner for Marketing.
Syngene is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors and a Category Award Winner for Innovation, Business Expansion, and Environmental.
PCI Pharma Services, a leading contract development and manufacturing organization and a Category Award Winner for Innovation, Business Expansion.
BostonGene is a biotechnology company specializing in advanced computational biology and precision medicine. It is also a Category Award Winner for Business Expansion, Research and Development (R&D), Innovation, Product Launches and Marketing.
EMIS is the UK’s leading integrated healthcare technology provider and a Category Award Winner for Innovation.
Medidata Solutions (Medidata), a leading provider of clinical trial solutions to the life sciences industry, is part of Dassault Systèmes and a Category Award Winner for Innovation and Product Launches.
West is a leading provider of innovative, high-quality injectable solutions and services. It is also a Category Award Winner for Safety.
Botanical Solution Inc. (BSI) is the world’s leading producer of Advanced Botanical Materials (ABM) that sustainably enable the production of gold-standard solutions for human and plant health and a Category Award Winner for Innovation and Business Expansion.
SecureCHEK AI is a SaaS provider specializing in AI-powered solutions and a Category Award Winner for Innovation, Marketing, Product Launches, and Diversity.
Catalent is a leading global contract development and manufacturing organization (CDMO) and a Category Award Winner for Innovation and Social.
Key Trends and Themes
Our research for the 2024 Pharmaceutical Technology Excellence Awards has identified several key themes and trends that are shaping the pharmaceuticals industry. A significant focus is on innovation, particularly in the integration of AI and digital platforms to enhance drug discovery and development processes. Companies like 1910 Genetics and Dyno Therapeutics are leveraging AI to overcome critical challenges in CNS therapeutics and gene therapy, respectively. Similarly, SecureCHEK AI is making strides in compliance and regulatory operations by integrating Generative AI, which streamlines content creation and approval processes, ensuring both innovation and compliance.
Sustainability is another major trend, with companies like Bayer and Syngene leading the way in sustainable packaging and reducing carbon footprints, reflecting the industry’s commitment to environmental responsibility. Botanical Solution is also noteworthy for its sustainable production of QS-21, a vaccine adjuvant, which avoids deforestation and enhances accessibility.
Business expansion remains a prominent theme, with companies such as OmniaBio and Eton Pharmaceuticals investing in new facilities and strategic acquisitions to bolster their capabilities in regenerative medicine and rare diseases. PCI Pharma Services is expanding its injectable drug delivery infrastructure, demonstrating a commitment to growth and innovation. This expansion is often coupled with efforts to improve global access to advanced therapies, as seen with OmniaBio’s initiatives in Canada.
Social responsibility and diversity are at the forefront, with initiatives from Novo Nordisk and Pfizer highlighting efforts to address childhood obesity and promote social justice. SecureCHEK AI and Chugai Pharmaceutical are recognized for their leadership in promoting gender diversity and empowering women in the workplace. Catalent’s community engagement programs further exemplify the industry’s dedication to social impact.
The industry is also witnessing a surge in strategic mergers and acquisitions, as demonstrated by AstraZeneca‘s acquisition of Fusion Pharmaceuticals and AbbVie‘s acquisition of ImmunoGen, aimed at strengthening oncology and immunology pipelines. This trend underscores the importance of collaboration and consolidation in driving innovation and expanding therapeutic offerings.
Furthermore, companies like BostonGene and Medidata are advancing digital platforms that enhance clinical trial processes and data management, while West Pharmaceutical Services is setting new standards in safety culture through behavioural safety initiatives. Syngene’s integration of AI in drug discovery and IFF Pharma Solutions’ brand leadership in controlled release technologies highlight the diverse areas of innovation within the sector.
Overall, the 2024 awards highlight a dynamic industry that is rapidly evolving through technological advancements, strategic growth, and a strong commitment to social and environmental responsibility. Congratulations to all our Winners!
Awards Report
Our Awards Report contains:
- Introduction and Themes
- All Excellence and Category Winners
- Featured Winner Profiles
- Country Winner Breakdown
You can download the full 50+ page report from the following link:
